$81.83
0.670.83%
al cierre: -
$81.83
0.000.00%
After hour: 5:25 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Edwards Lifesciences informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
oct 23
Estimación de BPA
$0.598
Estimación de ingresos trimestrales
$1.48B
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$5.69B
Analice el historial de beneficios de Edwards Lifesciences utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
EW | Edwards Lifesciences | $0.67 | $0.60 | — | — | $1.35B | $1.48B | — | — | 10/23/2025 | |
EW | Edwards Lifesciences | $0.70 | $0.62 | $0.67 | — | $1.63B | $1.49B | $1.53B | 3.01% | 07/24/2025 | |
EW | Edwards Lifesciences | $0.66 | $0.60 | $0.64 | 6.67% | $1.60B | $1.40B | $1.41B | 0.71% | 04/23/2025 | |
EW | Edwards Lifesciences | $0.64 | $0.55 | $0.59 | 7.27% | $1.53B | $1.36B | $1.39B | 1.91% | 02/11/2025 | |
EW | Edwards Lifesciences | $0.55 | $0.64 | $0.67 | 4.69% | $1.24B | $1.52B | $1.35B | -10.92% | 10/24/2024 | |
EW | Edwards Lifesciences | $0.66 | $0.69 | $0.70 | 1.45% | $1.53B | $1.65B | $1.63B | -1.09% | 07/24/2024 | |
EW | Edwards Lifesciences | $0.62 | $0.64 | $0.66 | 3.12% | $1.46B | $1.57B | $1.60B | 1.78% | 04/25/2024 | |
EW | Edwards Lifesciences | $0.64 | $0.64 | $0.64 | 0.00% | $1.35B | $1.49B | $1.53B | 2.95% | 02/06/2024 | |
EW | Edwards Lifesciences | $0.61 | $0.59 | $0.59 | 0.00% | $1.32B | $1.48B | $1.48B | 0.07% | 10/25/2023 | |
EW | Edwards Lifesciences | $0.63 | $0.65 | $0.66 | 1.54% | $1.37B | $1.50B | $1.53B | 2.00% | 07/26/2023 | |
EW | Edwards Lifesciences | $0.60 | $0.61 | $0.62 | 1.64% | $1.34B | $1.39B | $1.46B | 5.04% | 04/26/2023 | |
EW | Edwards Lifesciences | $0.51 | $0.61 | $0.64 | 4.92% | $1.33B | $1.33B | $1.35B | 1.35% | 01/31/2023 | |
EW | Edwards Lifesciences | $0.54 | $0.62 | $0.61 | -1.61% | $1.31B | $1.33B | $1.32B | -0.83% | 10/27/2022 | |
EW | Edwards Lifesciences | $0.64 | $0.64 | $0.63 | -1.56% | $1.38B | $1.40B | $1.37B | -1.86% | 07/28/2022 | |
EW | Edwards Lifesciences | $0.54 | $0.57 | $0.60 | 5.26% | $1.22B | $1.31B | $1.34B | 2.37% | 04/26/2022 | |
EW | Edwards Lifesciences | $0.50 | $0.55 | $0.51 | -7.27% | $1.19B | $1.36B | $1.33B | -2.21% | 01/26/2022 | |
EW | Edwards Lifesciences | $0.51 | $0.53 | $0.54 | 1.89% | $1.14B | $1.32B | $1.31B | -0.76% | 10/27/2021 | |
EW | Edwards Lifesciences | $0.34 | $0.55 | $0.64 | 16.36% | $925.00M | $1.28B | $1.38B | 7.50% | 07/29/2021 | |
EW | Edwards Lifesciences | $0.50 | $0.47 | $0.54 | 14.89% | $1.13B | $1.16B | $1.22B | 4.91% | 04/20/2021 | |
EW | Edwards Lifesciences | $0.49 | $0.53 | $0.50 | -5.66% | $1.17B | $1.19B | $1.19B | 0.17% | 01/27/2021 | |
EW | Edwards Lifesciences | $0.49 | $0.44 | $0.51 | 15.91% | $1.09B | $1.08B | $1.14B | 5.65% | 10/21/2020 |
Edwards Lifesciences (EW) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q1 | 2025-04-23 | $0.64 | $0.60 | 6.67 % |
| Q4 | 2025-02-11 | $0.59 | $0.55 | 7.27 % |
| Q3 | 2024-10-24 | $0.67 | $0.64 | 4.69 % |
| Q2 | 2024-07-24 | $0.70 | $0.69 | 1.45 % |
Edwards Lifesciences (EW) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-07-24 | $1.53B | $1.49B | 3.01 % |
| Q1 | 2025-04-23 | $1.41B | $1.40B | 0.71 % |
| Q4 | 2025-02-11 | $1.39B | $1.36B | 1.91 % |
| Q3 | 2024-10-24 | $1.35B | $1.52B | -10.9 % |
PREGUNTAS FRECUENTES
¿Cuándo Edwards Lifesciences (NYSE:EW) publicará los resultados?
Está previsto que Edwards Lifesciences (EW) presente resultados el octubre 23, 2025. Los últimos resultados se publicaron el julio 24, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Edwards Lifesciences (NYSE:EW)?
El BPA real fue de $0.67, que superó la estimación de $0.62.
¿Cuáles fueron los ingresos de Edwards Lifesciences (NYSE:EW)?
Los ingresos reales fueron $1.5B, que superó la estimación de $1.5B.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.